Recent Price Movement and Market Context
As of 08:45 PM on 22-Jan, Apollo Hospitals’ stock closed at ₹6,807.95, down by ₹19.3 or 0.28%. This decline is part of a broader short-term weakness, with the stock having fallen by 6.36% over the past week, significantly underperforming the Sensex’s 1.29% drop in the same period. The stock has been on a six-day losing streak, accumulating a negative return of 6.9% during this span. This underperformance is notable given the company’s long-term outperformance relative to the benchmark indices.
Moreover, the stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a prevailing bearish sentiment among traders and investors in the near term. However, rising investor participation is evident, with delivery volumes on 21 Jan increasing by 36.71% compared to the five-day average, indicating heightened trading activity and interest despite the price decline.
Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!
- - Clear entry/exit targets
- - Target price revealed
- - Detailed report available
Fundamental Strengths Supporting the Stock
Despite the recent price softness, Apollo Hospitals continues to demonstrate strong fundamental credentials. The company boasts a high Return on Capital Employed (ROCE) of 16.84%, reflecting efficient management and effective utilisation of capital. Its ability to service debt is robust, with a low Debt to EBITDA ratio of 1.48 times, signalling manageable leverage and financial stability.
Long-term growth remains healthy, with net sales expanding at an annualised rate of 16.66% and operating profit growing at 37.14%. The company has consistently delivered positive results for eight consecutive quarters, underscoring operational resilience. Notably, the latest half-year ROCE stands at 16.11%, operating profit to interest coverage ratio at 8.59 times, and quarterly net sales reaching a peak of ₹6,303.50 crore.
Valuation metrics also suggest the stock is attractively priced relative to its peers. With a ROCE of 17.9 and an enterprise value to capital employed ratio of 7.4, Apollo Hospitals trades at a discount compared to historical averages within its sector. Although the stock’s one-year return is slightly negative at -1.09%, profits have surged by 41.3% over the same period, resulting in a PEG ratio of 1.4, which indicates reasonable valuation in relation to earnings growth.
Institutional investors hold a significant 65.27% stake in the company, reflecting confidence from well-resourced market participants who typically conduct thorough fundamental analysis. Apollo Hospitals is also among the top 1% of companies rated by MarketsMojo out of over 4,000 stocks, highlighting its strong market reputation and quality.
Market Position and Industry Influence
With a market capitalisation of approximately ₹98,435 crore, Apollo Hospitals is the largest entity in its sector, accounting for 18.71% of the entire industry’s market value. Its annual sales of ₹23,264.70 crore represent nearly 29% of the sector’s total revenue, underscoring its dominant position. This scale provides the company with competitive advantages and resilience against sectoral headwinds.
Apollo Hospitals or something better? Our SwitchER feature analyzes this Largecap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Conclusion: Short-Term Price Pressure Amid Strong Fundamentals
The recent decline in Apollo Hospitals’ share price appears to be driven primarily by short-term technical factors and broader sectoral trends rather than any deterioration in the company’s underlying business. The stock’s fall below key moving averages and the six-day losing streak reflect cautious investor sentiment in the near term. However, rising delivery volumes suggest that interest remains elevated, potentially signalling accumulation by informed investors.
Fundamentally, Apollo Hospitals remains a strong performer with consistent profit growth, efficient capital management, and a commanding market position. Its valuation metrics indicate that the stock is trading at a discount relative to peers, supported by high institutional ownership and positive long-term prospects. Investors may view the current weakness as a temporary correction within an otherwise solid investment case.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
